Press Releases

WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) has opened an investigation into the development and implementation of overreaching, federal COVID-19 vaccination mandates and policies at the Department of Defense (DOD), U.S. Office of Personnel Management (OPM), Department of Labor (DOL), and Department of Health and Human Services (HHS). Chairman Wenstrup is requesting access to all documents, communications, and guidance utilized by these ...

WASHINGTON—Subcommittee on National Security, the Border, and Foreign Affairs Chairman Glenn Grothman (R-Wis.) and the Judiciary Subcommittee on Crime and Federal Government Surveillance Chairman Andy Biggs (R-Ariz.) will hold a joint field hearing titled “Biden’s Border Crisis and its Effect on American Communities” on August 8, 2023, at 2:00 p.m. PT. The joint ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued the following statement following Devon Archer’s four-hour transcribed interview with the committee: “Devon Archer’s testimony today confirms Joe Biden lied to the American people when he said he had no knowledge about his son’s business dealings and was not involved. Joe Biden was ‘the brand’ that his son sold around the world to enrich the Biden family. When Joe Biden was ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is furthering an investigation into how Hunter Biden has used his new art career to peddle influence in and access to the White House. Despite the White House stating that the identity of Hunter Biden art purchasers would be concealed, Democrat donor Elizabeth Hirsch Naftali was revealed to have purchased at least one piece of Hunter Biden’s artwork. She was appointed by President Biden to the ...

“The lack of action has cast a shadow over the industry” WASHINGTON—The Subcommittee on Health Care and Financial Services yesterday held a hearing titled “Hemp in the Modern World: The Yearslong Wait for FDA Action” to examine the failures of the Food and Drug Administration (FDA) to regulate CBD and hemp-derived products. Despite the 2018 ...

WASHINGTON — The Select Subcommittee on the Coronavirus Pandemic held a hearing titled “Because I Said So: Examining the Science and Impact of COVID-19 Vaccine Mandates” to evaluate the necessity and effectiveness of overreaching COVID-19 vaccine mandates and consider the erosion of public trust that stemmed from coercive vaccination policies. Select Subcommittee members asked expert witnesses about the effects on military readiness caused by separating military service members who ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) opened today’s hearing titled “Hemp in the Modern World: The Yearslong Wait for FDA Action” by discussing the failures of the Food and Drug Administration (FDA) to regulate hemp products. Instead, the FDA is asking Congress for more regulatory authority which has led ...

WASHINGTON – Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Congresswoman Eleanor Holmes Norton (D-D.C.) introduced the D.C. Robert F. Kennedy (RFK) Memorial Stadium Campus Revitalization Act, bipartisan legislation that transfers administrative jurisdiction over the RFK stadium site from the Secretary of the Interior to the Administrator of the General Services Administration (GSA). The bill will allow GSA to enter into a ...

WASHINGTON – Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) delivered opening remarks at a full committee hearing titled “Oversight and Reauthorization of the Office of National Drug Control Policy.” In his opening statement, Chairman Comer emphasized that fentanyl is flowing into our communities at a fast rate and is ...

ONDCP must be equipped and directed to take all appropriate actions to fight this ongoing drug crisis and save lives. WASHINGTON – Today, the House Committee on Oversight and Accountability held a hearing titled “Oversight and Reauthorization of the Office of National Drug Control Policy.” At the hearing, members emphasized that fentanyl and ...